Hematology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - Critical Care Canada Forum

Echinocandins in the ICU: A Clinical Advance

Toronto, Ontario / November 11-13, 2008

Invasive and septic Candida infections are associated with high levels of mortality and morbidity. However, the agents most commonly used to empirically treat these pathogens are associated with significant drawbacks: there are now high...

33rd Congress of the European Society for Medical Oncology

Guidelines Support for Low Molecular-weight Heparin for Long-term Recurrent VTE Prevention in Cancer Patients

Stockholm, Sweden / September 12-16, 2008

Stockholm - The risk posed by cancer for venous thromboembolism (VTE) and pulmonary embolism appears to be insufficiently appreciated. In patients hospitalized for cancer, anticoagulation is a recognized standard of care, but the much...

13th Congress of the European Hematology Association

Prevention and Treatment of Venous Thromboembolic Disorders: Future Needs

Copenhagen, Denmark / June 12-15, 2008

Copenhagen - Total hip and knee replacement orthopedic surgery patients are in the highest risk category for venous thromboembolic (VTE) sequelae, both deep-vein thrombosis (DVT) and pulmonary embolism, and the risk is known to extend well...

XXVIII International Congress of the World Federation of Hemophilia

Evolution of Recombinant Factor VIII: Progress in Patient Safety

Istanbul, Turkey / June 1-5, 2008

Istanbul - A variety of recombinant FVIII (rFVIII) products are now available to treat patients with hemophilia A. Product safety has improved since the initial use of human and mammalian proteins in first-generation processes. Even less...

XXVIII International Congress of the World Federation of Hemophilia

Improving Quality of Life in Patients with Hemophilia with Inhibitors

Istanbul, Turkey / June 1-5, 2008

Istanbul - The development of antibodies occurs frequently in patients with severe hemophilia A or B, complicating both on-demand and prophylactic treatment. Recommended treatment options include activated prothrombin complex concentrate...

49th Annual Meeting and Exposition of the American Society of Hematology

Less Toxic Broad-Spectrum Antifungals: Facilitating Infection Control in Hematological Malignancies

Atlanta, Georgia / December 8-11, 2007

Atlanta - The substantial morbidity and mortality imposed by invasive fungal infections in patients with hematological malignancies can be largely contained by a high index of suspicion and early use of broad-spectrum antifungal drugs....

49th Annual Meeting and Exposition of the American Society of Hematology

From First-line to Consolidation Therapies: Exploring Options in Hematologic Malignancies

Atlanta, Georgia / December 8-11, 2007

Editorial Overview Joseph M. Connors, MD, ABIM, FRCPC Chair, Lymphoma Tumor Group BC Cancer Agency Clinical Professor of Medicine University of British Columbia Vancouver, British Columbia

49th Annual Meeting and Exposition of the American Society of Hematology

Extending Time to Progression in Refractory Multiple Myeloma with Novel Regimens

Atlanta, Georgia / December 8-11, 2007

Atlanta - After substantial progress in the development of more effective front-line therapies for multiple myeloma (MM), the standard for treatment of refractory disease is now also evolving. New findings indicate that meaningful...

49th Annual Meeting and Exposition of the American Society of Hematology

Clinical Challenges in Non-Hodgkin’s Lymphoma: The Use of Monoclonal Antibodies in 2008

Atlanta, Georgia / December 8-11, 2007

Studies presented at the American Society of Hematology reinforce the increasingly important role of therapies targeted at the CD20 surface protein in hematologic malignancies. In indolent non-Hodgkin’s lymphoma (NHL), final results of a...

XXIst Congress of the International Society on Thrombosis and Haemostasis

Hemostatic Control in the Challenging Surgery and Trauma Patient

Geneva, Switzerland / July 6-12, 2007

Editorial Overview Keyvan Karkouti, MD, FRCPC Staff Anesthesiologist UHN-Toronto General Hospital Associate Professor of Anesthesia University of Toronto Toronto, Ontario

PAGE 6 OF 8   1 2 3 4 5 6 7 8